Sutton Wealth Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Sutton Wealth Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,355	Closed	-$38K	–	840
2022 Q4	$38K	Hold	1,355	–	–	0.01%	473
2022 Q3	$38.1K	Hold	1,355	–	–	0.02%	448
2022 Q2	$47.1K	Hold	1,355	–	–	0.02%	400
2022 Q1	$48.6K	Buy	1,355 +5	+0.4%	+$142	0.02%	411
2021 Q4	$31.4K	Buy	1,350 +7	+0.5%	+$143	0.01%	558
2021 Q3	$25.5K	Hold	1,343	–	–	0.01%	619
2021 Q2	$27.1K	Hold	1,343	–	–	0.01%	611
2021 Q1	$24.6K	Buy	1,343 +855	+175%	+$15.9K	0.01%	606
2020 Q4	$9.81K	Hold	488	–	–	﹤0.01%	813
2020 Q3	$9.15K	Hold	488	–	–	﹤0.01%	769
2020 Q2	$11K	Hold	488	–	–	0.01%	686
2020 Q1	$7.24K	Hold	488	–	–	﹤0.01%	743
2019 Q4	$9.41K	Hold	488	–	–	﹤0.01%	836
2019 Q3	$9.68K	Hold	488	–	–	0.01%	791
2019 Q2	$10.3K	Hold	488	–	–	0.01%	763
2019 Q1	$9.97K	Hold	488	–	–	0.01%	781
2018 Q4	$9.71K	Hold	488	–	–	0.01%	753
2018 Q3	$9.39K	Hold	488	–	–	0.01%	797
2018 Q2	$7.45K	Hold	488	–	–	0.01%	879
2018 Q1	$9.15K	Hold	488	–	–	0.01%	832
2017 Q4	$9.39K	Hold	488	–	–	0.01%	801
2017 Q3	$8.72K	Buy	+488	New	+$8.03K	0.01%	791

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Sutton Wealth Advisors's AMPH Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2023, closing a stake of 1,355 shares — an estimated $38K sold.

Sutton Wealth Advisors first reported a position in AMPH in Q3 2017 and held it in 22 quarters. The position peaked at $48.6K in Q1 2022. 218 funds tracked by Wall St. Rank hold AMPH as of Q1 2023.

Sutton Wealth Advisors reported no remaining Amphastar Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Sutton Wealth Advisors sold 1,355 Amphastar Pharmaceuticals shares in Q1 2023, an estimated $38K.
Sutton Wealth Advisors first reported a position in Amphastar Pharmaceuticals in Q3 2017 and held it in 22 quarters.
Sutton Wealth Advisors's Amphastar Pharmaceuticals position peaked at $48.6K in Q1 2022.
218 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.